Firefly Neuroscience, INC 10-Q quarterly reports

Firefly Neuroscience reported a significant revenue increase in Q3 2025 driven by the Evoke acquisition, yet net losses expanded due to derivative fair value changes and an intangible asset impairment.

Firefly Neuroscience, Inc. reported a significant net loss for Q2 2025, driven by increased operating expenses and non-cash charges, despite a substantial revenue increase primarily due to the Evoke Neuroscience acquisition.

Firefly Neuroscience's Q1 2025 shows revenue growth alongside a significant increase in net loss, highlighting ongoing concerns about the company's financial stability and internal controls.

Firefly Neuroscience, formerly WaveDancer, reports its Q3 2024 results, reflecting a reverse merger and ongoing development of its Brain Network Analytics platform.

Firefly Neuroscience, formerly WaveDancer, reported its second quarter 2024 results, highlighting a strategic shift towards commercializing its Brain Network Analytics (BNA) platform after a recent merger.

WaveDancer Inc. reported a net loss of $673,950 for the first quarter of 2024, while navigating a planned merger and ongoing financial constraints.